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Abstract
Background: Assessment of subjective quality of life (QOL) of persons with multiple sclerosis (MS) could
facilitate the detection of psychosocial aspects of disease that may otherwise go unrecognized. The
objectives of the study were to (i) compare the QOL ratings of relapsing remitting (RRMS) and progressive
(PMS) types of MS with those of a general population group and the impression of their family caregivers;
and (ii) assess the association of demographic, clinical, treatment, depression, and caregiver variables with
patients' QOL.
Methods: Consecutive clinic attendees at the national neurology hospital were assessed with the 26 -item
WHOQOL Instrument, Beck's Depression Inventory and Expanded Disability Scale. Caregivers rated their
impression of patients' QOL and attitudes to patients' illness.
Results: The 170 patients (60 m, 109 f) consisted of 145(85.3%) with RRMS and 25 with PMS, aged
32.4(SD 8.8), age at onset 27.1(7.7), EDSS score 2.9 (1.8), and 76% were employed. The patients were
predominantly dissatisfied with their life circumstances. The RRMS group had higher QOL domain scores
(P < 0.001), and lower depression(P > 0.05) and disability (P < 0.0001) scores than the PMS group. Patients
had significantly lower QOL scores than the control group (P < 0.001). Caregiver impression was
significantly correlated with patients' ratings. Depression was the commonest significant covariate of QOL
domains. When we controlled for depression and disability scores, differences between the two MS
groups became significant for only one (out of 6) QOL domains. Patients who were younger, better
educated, employed, felt less sick and with lesser side effects, had higher QOL. The predictors of patients'
overall QOL were disability score, caregiver impression of patients' QOL, and caregiver fear of having MS.
Conclusion: Our data indicate that MS patients in stable condition and with social support can hope to
have better QOL, if clinicians pay attention to depression, disability, the impact of side effects of treatment
and family caregiver anxieties about the illness. The findings call for a regular program of psychosocial
intervention in the clinical setting, to address these issues and provide caregiver education and supports,
in order to enhance the quality of care.
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Background
Multiple sclerosis (MS) is a chronic debilitating disease,
arising from inflammation and demyelination of nerves
in the central nervous system, characterized by remissions
and relapses, affecting mostly young people and resulting
in various degrees of physical and social disability.
Although there is currently no cure for the disease, the
available immuno-modulatory treatments may slow the
appearance of new symptoms[1,2].
In recent times, attention has been focused on health-
related quality of life (QOL) as an outcome measure in
MS because the concept assesses the broader impact of MS
and might indicate less obvious disease burdens[1,3,4]. In
this regard, some of the areas of concern in the literature
include the impact on QOL, of depression, physical disa-
bility [5-8], disease progression [3], neuropathic pain [9],
drug side effects [1,2], as well as sexual, bladder and bowel
dysfunctions[10]. Other issues of concern are the impact
of social support, unawareness of illness [11], cognitive
impairment [12], caregiver attitudes/burden[5,13,14],
and financial costs [15-17].
With regard to the above issues, the predominant findings
are that, compared with the general population, QOL
deteriorates early in the course of MS [18-20], and those
with the relapsing remitting type have higher QOL than
the progressive types[21,22]. In addition, the most impor-
tant predictors of QOL are depression, physical disability
and disease progression[3,5-7,23]. The contribution of
socio-demographic factors[8,24] and drug side effects
[1,2] is controversial, and financial burden increased with
disease progression [15-17].
A review of the literature showed that, with the exception
of the report from Iran [6], all the reports on QOL in MS
have emanated from the temperate/Mediterranean cul-
tures of Europe and North America, where the disease is
traditionally thought to have a higher prevalence and
severity[25], compared with countries in the lower lati-
tudes, such as the Arab world[26,27]. Kuwait, a city-state
in the Persian Gulf, is one of the relatively low latitude
countries where a rising incidence and prevalence of MS
has recently been reported[26]. For example, while the
prevalence and incidence of MS in Europe are estimated to
be 83 per 100,000 and 4.3 cases per 100,000, respec-
tively[25], the figures for the total population in Kuwait
are 14.77 per 1000,000 and 2.62 cases per 100,000,
respectively[26] (increased from pre-1993 levels of 6.68
and 1.05, respectively, for prevalence and incidence). Spe-
cifically for Kuwaiti nationals, the mean incidence rate
between 1993 and 2000 was 3.45 per 100,000 population
per year (for women it was 7.79/100,000), and the preva-
lence rate for the same period was 31.15 per 100,000 pop-
ulation [26].
A study of QOL among Kuwaitis is valuable because it
presents the perspectives from a country where (compared
with the western world) the disease seems to have an ear-
lier age at onset, is thought to have relatively milder clini-
cal severity [26,27], an effective national social welfare
system is in place, and family social support is much avail-
able in the conservative culture. As a result of the national
social welfare system, the Kuwaiti patients have had over
a decade experience of free availability of the immuno-
modulatory drugs. It would, therefore, be interesting to
see whether all these favorable factors would make for
good QOL among the MS patients, in comparison with a
socio-demographically matched general population sam-
ple.
Our review of the literature showed that there is paucity of
information on the relationship of family caregiver's atti-
tudes to the illness and caregiver's impressions of the
patient's QOL, with the QOL of the patient [5,13]. This
perspective is important because the psychological litera-
ture on "expressed emotions" (i.e., the impact of emo-
tional interactions in the family on clinical outcome) has
consistently shown that family caregiver's emotional
appraisal of the patient has an impact on clinical outcome
[28]. Katschnig [29] has suggested that it is necessary to
involve family members for additional views on aspects of
QOL. This issue is particularly important in MS because of
the widely reported cognitive impairment among the
patients[12], the consequent unawareness of functional
deficit, and their impact on the well-being of the patient
and family caregiver [13].
The objectives of our study were as follows:
- Using the 26-item WHO QOL Instrument (WHOQOL-
Bref), to compare the QOL ratings of relapsing remitting
(RRMS) and primary/secondary progressive MS (PMS),
with those of a socio-demographically matched general
population sample and the impression of their family car-
egivers (FC);
- to assess the association of the following variables with
the patients' QOL: demographic factors, type of drug treat-
ment, side effects of treatment, duration of illness, depres-
sion, physical disability, and caregiver attitudes to the
patient's illness;
- to examine the concordance between the ratings of the
patients and the family caregivers' impressions of the
patients' QOL;
- to assess the characteristics of the patient and illness, as
well as family caregiver impressions and attitudes that can
predict the patient's subjective QOL.BMC Neurology 2007, 7:31 http://www.biomedcentral.com/1471-2377/7/31
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Based on evidence from the literature, we hypothesized as
follows: First, in view of available family and national
social supports, most patients would be satisfied with
QOL items related to family supports and the affluent
national economy, but not with items related to health
and general well being. Patients with RRMS would have
significantly higher QOL domain scores than those with
PMS, while all MS patients would have significantly lower
scores than the matched general population control
group. Second, socio-demographic variables and type of
drug treatment would have no significant association with
QOL. However, patients with shorter duration of illness,
who had no side effects of treatment, scored low on the
depression and disability scales, and whose family car-
egivers had positive attitudes to the illness, would have
higher QOL scores[30].
Third, there would be highly significant concordance
between patient's ratings and caregiver's ratings of the
patient's QOL. Fourth, the most significant predictor of
the patient's QOL would be the caregiver's impression of
the patient's QOL [31-34].
The clinical relevance of these hypotheses is that they
could help to define a subset of stable patients whom cli-
nicians need to give focused attention, and identify the
characteristics of patients which psychosocial interven-
tion should target to make for improved quality of care.
Methods
Operational definitions
We accepted the WHO definition of QOL as individuals'
perception of life in the context of the culture and value
system in which they live and in relation to their goals,
expectations, standards and concerns[35]. Our focus was
on subjective QOL, as distinct from objective QOL[36].
We defined subject's satisfaction as the level of positive
appreciation for each item. We quantified each group's
satisfaction with each item as at least 50% of respondents
in the group positively appreciating the item (i.e., propor-
tion of subjects in the group rating satisfaction for the
item as "satisfied" or "very satisfied") ; dissatisfaction (<
50%); bare satisfaction (50 – 65%); moderate satisfaction
(66 – 74%); and highest satisfaction (≥ 75%)[31,36].
The setting
The study took place at the outpatient clinic of the Neurol-
ogy Department, Ibn Sina Hospital, which is the national
hospital for neurology and neurosurgery in Kuwait. This
hospital provided the sample for the epidemiologic stud-
ies of MS[26,27], and so we can examine how our clinic
sample is representative of the total population of MS
patients in Kuwait. All procedures and treatments admin-
istered to Kuwaiti nationals are free-of-charge, including
hospital registration. The hospital is highly equipped with
radiologic (e.g., MRI), neurophysiologic (e.g., evoked
potentials), and laboratory facilities, as well as consultant
neurology staff and immuno-modulatory drugs.
Subjects
The patients were consecutive outpatient clinic attendees
who fulfilled the study's inclusion criteria. First, the
patients had been formally diagnosed for at least six
months, using the Poser Criteria [37], and were now
attending the clinic for routine follow-up or exacerbation
of illness. However, patients with a flare-up of illness were
hospitalized and interviewed only when they had become
stable. That is, all patients were in stable clinical condition
at the time of interview. Second, each patient was accom-
panied by at least one family member or friend who lived
with them, was responsible for caring for them at home
and could complete the questionnaires in Arabic.
The general population group was selected by quota sam-
pling from our WHOQOL-Bref data base for Kuwait, to
match the patients by gender, age, occupation, marital sta-
tus and level of education.
The WHOQOL – Bref
This is a 26 -item self -administered generic questionnaire,
a short version of the WHOQOL – 100 scale[35]. It
emphasizes subjective experiences (i.e., subjective QOL)
rather than objective life conditions (or objective
QOL)[36]. It was developed in a wide range of cultural
and clinical settings, including neurology. It is made up of
domains and facets (or sub – domains). Domains are
broad groupings (e.g., physical/psychological) of related
facets. The items on "overall rating of QOL" (OQOL) and
subjective satisfaction with health, are not included in the
domains, but are used to constitute the "general facet on
health and OQOL". There are two models of the WHO-
QOL -Bref. One model has six domains, namely, physical
health, psychological health, level of independence, social
relationships, environment, and spiritual. To derive the
second (4 – domain) model, the domain of level of inde-
pendence was merged with that of physical health, while
the "spiritual" domain was added to the psychological.
Modification of the WHOQOL – Bref for the impression of 
caregivers
In order to produce the version of the WHOQOL – Bref
with which the family caregivers rated their impression of
the patients' QOL, we used the method of Sainfort's
group[38], by giving a new direction to each item, so that
the caregiver could rate the patient as an observer. The
modification of the WHOQOL – Bref was thus mini-
mal[31].
The internal consistency of the WHOQOL -Bref, as
assessed by Cronbach's alpha coefficient for the responsesBMC Neurology 2007, 7:31 http://www.biomedcentral.com/1471-2377/7/31
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of all subjects, was very high for the patients (0.94), the
caregivers' impressions (0.93), and the general popula-
tion control group (0.90).
Other assessments
The patients were also assessed with the 21 -item Beck's
Depression Inventory (BDI) [39] and the expanded disa-
bility status scale [40]. In addition, we assessed the pres-
ence of the following side effects of treatment : influenza
-like feeling after injections (e.g., fever, muscle and joint
aches); inflammation at site of injection (redness, pain
and heat at site of injection); sadness and suicidal idea-
tion; tiredness and fatigue; difficulty in breathing and pal-
pitations; diarrhoea, constipation and nausea. The
response options for this assessment of side effects were:
never; rarely; sometimes; most times; always. On the basis
of clinical experience with the relatives, we assessed their
attitudes to the patients' illness by seeking their responses
to the following items: caregiver feeling sad about the
patient's illness; caregiver feeling disgusted about patient's
illness; caregiver feeling tired and exhausted about caring
for the patient; and caregiver feeling anxious about the
possibility of having MS. The response options were: not
present; a little; moderately; a lot.
The internal consistency of the BDI and caregiver atti-
tudes' questionnaire, as assessed by Cronbach's alpha
coefficient for the responses of all subjects was high: 0.93
for the BDI and 0.74 for the caregiver attitudes' question-
naire.
Data collection procedure
The questionnaires were translated into Arabic by the
method of back – translation and have been used in recent
studies in an Arab country to assess psychiatric and diabe-
tes patients and their family caregivers [31-34]. In a pilot
exercise, the instruments were found to be suitable to the
cultural setting.
The WHOQOL questionnaires, the BDI, side effects and
attitudes of caregivers' questionnaires were administered
by a female native Arab research assistant. One neurolo-
gist made all the EDSS assessments. At the preliminary
stage of the study, the research assistant was trained in the
use of the questionnaires using patients who did not par-
ticipate in the main study. The study commenced when
the research team was satisfied that the research assistant
could confidently administer the questionnaires to
patients. Patients and caregivers completed the question-
naires privately and without interference from the
research assistant, after clarification of the objectives of
the study and the meaning of the items. Illiterate patients
were assisted by their educated relatives to complete the
questionnaire, after the caregiver had completed his or her
own. Literacy in Arabic language is very high in Kuwait.
The study was carried out in compliance with the Helsinki
Declaration. Ethical approval for the work was obtained
from the Faculty of Medicine, Kuwait University, and Ibn
Sina Hospital, Kuwait. Patients and family caregivers gave
verbal informed consent after the objectives of the study
had been explained to them. They were duly informed
that there would be no negative consequences for declin-
ing to participate. As is well known in our culture for such
non-invasive studies[31], all families approached freely
consented to participate in the study, especially as the
approach was made by clinic staff in charge of the cases.
The physician in-charge of each case assisted the research
assistant to record the relevant clinical data. The type of
drug treatment was recorded.
Data analysis
Data were analyzed by the SPSS – version 11. For the first
hypothesis, the pattern of frequency counts was used to
assess group satisfaction with QOL items. Summary scores
were generated by organizing the items of the WHOQOL-
Bref into the six domains and four domains previously
highlighted. We compared mean differences in domain
scores for the relapsing remitting and the progressive MS
types by independent sample t-test. A similar analysis was
done with the total scores of the BDI and the EDSS score.
QOL domain scores of the patients (as a group) were com-
pared with those of the matched general population
group using independent sample t-test. For the second
hypothesis, the relationship between age, duration of ill-
ness, depression, EDSS score and QOL domain scores was
assessed by Pearson's correlation. The association
between other socio-demographic variables (level of edu-
cation, occupation and marital status), type of drug treat-
ment and QOL was assessed by one-way ANOVA. In view
of the fact that a number of the socio-demographic and
clinical variables were significantly associated with QOL
domain scores in these uni-variable analyses, analysis of
covariance (ANCOVA) was used to control for the impact
of these variables on the differences in QOL domain
scores between the two MS groups. For the third hypothe-
sis, the concordance between patient's WHOQOL-Bref
ratings and the impression of the caregiver was assessed in
two ways. First, we used Kendall's tau to examine the cor-
relation between the corresponding QOL items and
domain scores (Kendall's tau was preferred because it is
more conservative than Pearson's correlation, as it takes
ties into consideration). Second, we used intra-class corre-
lation to examine the internal consistency of the patient -
caregiver rating. For the fourth hypothesis, the predictors
of patients' QOL (based on patients' general facet on
health & QOL as dependent variable) was assessed in step-
wise regression analysis. Missing data were handled by
excluding cases analysis by analysis. Effect size calcula-
tions were used for verification in the cases where it wasBMC Neurology 2007, 7:31 http://www.biomedcentral.com/1471-2377/7/31
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suspected that a test of significance could have led to a sta-
tistical error because of sample size. All tests were two-
tailed. A Bonferroni correction (P = 0.01) was used for
multiple tests; otherwise, the level of statistical signifi-
cance was set at P < 0.05.
Results
Socio-demographic and clinical characteristics (Tables 1 
&2)
Over a period of seven months, 170 consecutive attendees
at the clinic met our inclusion criteria and agreed to par-
ticipate in the study. They consisted of 60 men (35.5%)
and 109 women (64.5%) (the gender of one patient was
not recorded). Most (145 or 85.3%) had relapsing remit-
ting MS (RRMS), while 22 (12.9%) and 3 (1.8%) had sec-
ondary progressive and primary progressive MS (PMS),
respectively. Of those with RRMS, 100 (69.4%) were
women, while women constituted 9(36%) of those with
SPMS. They were aged 32.4 (SD 8.8) years (range 16 – 55,
median 31). Age at onset of illness was 27.1 (SD 7.7,
median 26.0) years. Duration of illness was 5.4 (SD5.3)
years (range six months to 30 yrs, median 4 yrs). They had
been on treatment for 2.9 (SD2.6) years (range six months
to 14 yrs, median 2.5 yrs). The mean EDSS score was 2.7
(SD 1.8, median 2.5, mode 1.0). Using EDSS scores, 139
(82.2%) had mild disease (EDSS score 1–3.5), 22
(13.0%) had moderately severe disease (4 – 6.5), and 8
(4.7%) had severe disease (7–9). While the men had sig-
nificantly higher EDSS scores (P = 0.008), there were no
significant gender differences in age, education, occupa-
tion, marital status, age at onset of illness, duration of ill-
ness and depression (BDI) score (P > 0.05). The rate of
formal unemployment was 32 (23.9%). Table 1 shows
that the patients were well matched with the general pop-
ulation control group (N = 171), by gender, age, educa-
tion, occupation and marital status (P > 0.05).
Table 2 shows that those with RRMS tended to be younger
(P = 0.04), in formal employment (P < 0.0001), had been
ill for a shorter period (P < 0.0001), and had much lower
disability scores (P < 0.0001).
Satisfaction and QOL domain scores (Tables 3 &4)
Table 3 shows that, using the operational definitions ear-
lier highlighted, the patients were predominantly either
dissatisfied or barely satisfied with various aspects of their
life circumstances. However, the areas that they were
highly satisfied with concerned transportation and availa-
bility of money for needs. Accordingly, Table 4 shows that
when compared with the general population group by
gender and MS type, the patients had much significantly
lower QOL domain scores (P mostly < 0.001). However,
it is noteworthy that in the case of QOL environment
domain (which includes items on money, transport,
information), patients had similar scores with the control
group by gender (Table 4A), and those with RRMS also
had similar scores with the control group (Table 4B) for
this domain (P > 0.05). Furthermore, while there were no
significant gender differences in QOL domain scores (P >
0.05; Table 4A), those with RRMS had much significantly
higher scores than patients with PMS in all the domains (P
< 0.0001), using uncorrected scores (Table 4B).
Table 1: Gender differences in patients' socio-demographic characteristics versus general population control group
Variables Men (% or 
SD) N = 60 
(1)
Women (% or 
SD) N = 109 
(2)
X2 Df P Control: 
men N = 61
(%/SD) (3)
Control: 
women 
N = 110
(%/SD) (4)
Gender 
differences b/w 
pts & control 
P level
Education: N = 60/109 1.30 2 0.52
Primary/high school 35(58.3) 54(49.6) 38(62.3) 47(42.7) 1 Vs 3: P < 0.08
College/PG 25(41.7) 55(50.5) 23(37.7) 63(57.3) 2 Vs 4: P < 0.4
Occupation: N = 50/83 5.70 3 0.13
Unemployed/student 14(28.0) 37(44.6) 17(27.9) 54(49.1) 1 Vs 3: P < 0.9
Medium/high skill 36(72.0) 46(55.5) 45(71.6) 56(50.8) 2 Vs 4: P < 0.6
Marital: N = 60/108 0.35 2 0.84
Single 32(53.3) 58(53.7) 25(40.9) 52(47.2) 1 Vs 3: P < 0.2
Married 28(46.7) 50(46.3) 36(59.0) 58(52.7) 2 Vs 4: P < 0.4
Age: N = 58/108 32.4(7.6) 32.5(9.4) ns 32.3(7.6) 32.7(9.1) ns
Age onset of illness 26.9(6.8) 27.3(8.2) ns
Duration illness(yrs): N = 60/109 5.7(5.4) 5.2(5.3) ns
Disability score* (EDSS): N = 60/108 3.2(2.1) 2.4(1.6) 2.7 166 0.008
Depression score: (BDI): N = 49/97 14.0(11.4) 14.4(11.2) Ns
* EDSS classification (N = 169): Mild: 1–3.5 (139 or 82.2%); moderate: 4 – 6.5 (22 or 13.0%); severe: 7–9 (8 or 4.7%) Mean EDSS = 2.7 (1.8); 
median = 2.5; mode = 1.0BMC Neurology 2007, 7:31 http://www.biomedcentral.com/1471-2377/7/31
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Factors associated with WHOQOL domain scores in 
univariate analysis
Age
The correlation (Pearson's) between age and QOL
domain scores was negative for all the domains, but
reached significance for only the following: independence
(r = -0.23, N = 141, P = 0.006), and social relations (r = -
0.21, N = 139, P = 0.01).
Education
Subjects with at least college education had the highest
scores, while the illiterate had the least scores in all
domains. After Bonferoni correction, this tendency
reached significance for only the independence domain (F
= 5.9, df = 2/163, P = 0.003).
Occupation
Students and those in medium/high skill work scored sig-
nificantly higher than the unemployed, in the social rela-
tions domain (F = 7.0, df = 3/124, P = 0.001), and the
general facet on health and QOL (F = 7.0, df = 3/127, P =
0.001).
Table 3: Comparative level of group satisfaction with QOL items
3A: Patients
Highest satisfaction
(≥ 75% subjects)
Moderate satisfaction 
(66 – 74% subjects)
Bare satisfaction (50–65% subjects) Dissatisfied (< 50% of subjects)
Satisfaction with transport (76%). Satisfaction with money to meet 
needs (66%).
Health satisfaction(57), life 
meaningful(56) Safety(57), health 
environ(58), bodily appearance 
(53), sleep(52), ADL(53), self-
satisfaction(58), personal 
relations(55), friends' support(50), 
living place satisfaction(63), access 
to health service(55).
OQOL(41), feeling pain(47), 
medical treatment need(25), enjoy 
life(46), ability to concentrate(39), 
energy(33), information for 
health(42), leisure activities(45), 
ability to get around(46), work 
capacity(46), sex satisfaction(45), 
negative feelings(17).
3B: General population control 
group
Highest satisfaction (≥ 75% 
subjects)
Moderate satisfaction (66 – 74% 
subjects)
Bare satisfaction (50–65% subjects) Dissatisfied (< 50% of subjects)
OQOL(81%), ability to get 
around(82%), work capacity(77%)
Health satisfaction(73%) medical 
treatment need(69), self-
satisfaction(74), personal 
relations(70), sex satisfaction(66), 
living place satisfaction(72)
Feeling pain(51), life 
meaningful(60), feeling safe(60), 
energy for life(55), sleep(58), 
ADL(65), support from friends(50)
Enjoy life(44), ability to 
concentrate (40), healthy 
environment around(49), 
money(42), information (39), 
leisure activities(26), access to 
health service(45), negative 
feelings (17%).
Note: OQOL = overall QOL; ADL = activities of daily living
Table 2: Diagnostic differences in socio-demographic characteristics
Variables Relapsing remitting (% or SD) Progressive types (% or DS) X2or T Df value P value
Education: N = 145/25 2.9 2 ns
Primary/high school 67 (46.2) 16 (64.0)
College/PG 73 (50.3) 8 (32.0)
Occup: N = 114/20 28.1 3 0.001
Unemployed/student 23 (20.2) 9 (45.0)
Medium/high skill 57 (50.0) 1 (5.0)
Marital: N = 144/25 0.23 2 ns
Single 64 (44.4) 10 (40.0)
Married 66 (45.8) 12 (48.0)
Gender: N = 60/109 8.9 1 0.003
Men 44 (73.3) 16 (26.7)
Women 100 (91.7) 9 (8.3)
Age: N = 144/23 31.9 (8.8) 35.9 (7.5) 2.1 165 0.04
Age onset illness 27.3 (7.9) 26.2 (6.3) 0.6 ns
Duration illness (yrs) 4.6 (4.2) 9.8 (8.1) 4.8 168 0.001
Disability: N = 144/25 2.2 (1.1) 5.9 (1.9) 13.8 167 0.001
Depression: N = 126/21 13.7 (10.6) 16.7 (14.4) 1.1 ns*
* Effect size = 0.27 (95% C.I. = -0.20 – 0.73)BMC Neurology 2007, 7:31 http://www.biomedcentral.com/1471-2377/7/31
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Marital status
There were no significant differences in QOL domain
scores for marital status groups (P > 0.05).
Duration of illness and treatment
In all the domains, duration of illness and treatment were
negatively correlated with QOL domain scores. In the case
of duration of illness, the correlation was highly signifi-
cant for all domains (r ranged from -0.26 to -0.37, P
mostly < 0.001), except the spiritual domain (P = 0.04).
For duration of treatment the correlation reached signifi-
cance after Bonferroni correction, for social relations (r =
-0.35, P < 0.0001).
Disability (EDSS) and depression (BDI)
The correlation between QOL domain scores, on the one
hand, and EDSS and BDI scores, on the other hand, was
negative. For EDSS, the correlation was highly significant
for all domains (r ranged from -0.35 to -0.54, P < 0.0001).
The correlations were also highly significant for BDI (r
ranged from -0.24 to -0.36), except for the general facet (r
= -0.17, P = 0.04).
Caregiver attitudes to patient's illness
Patients had a tendency to have lower QOL domain scores
and higher depression scores, if the family caregiver had
either of the following attitudes: feeling sad about
patient's illness, feeling disgusted about the illness, feeling
exhausted about caring for the patient and feeling afraid
about having the illness. For caregiver feelings of sadness
and exhaustion, this tendency did not reach significance
(P > 0.05). But it reached significance in the psychological
domain, for caregiver fear of illness (t = 2.4, df = 130, P =
0.02), and in the independence domain, for caregiver feel-
ing disgusted about the illness (t = 2.7, df = 124, P =
0.009).
Association of side effects of treatment with QOL domain 
scores
Influenza -like effects, inflammation and diarrhoea
The tendency for patients with influenza -like effects,
inflammation at site of injection and diarrhoea, to have
lower QOL scores and higher depression scores, did not
reach significance (P > 0.05).
Table 4: Comparison of QOL domains by gender and MS type versus matched control groups
A. By gender:
WHOQOL-Bref domains MS men(SD): 1 MS women(SD): 2 P level Control men(SD): 
3 N = 61
Control 
women(SD): 4
N = 110
P level differences b/w 
pts & control groups:
1 vs 3; 2 vs 4, 
respectively*
Physical health: N= 58/108 9.8(2.6) 9.6(2.3) Ns 11.2(1.8) 10.5(2.0) P < 0.0008; 0.002
Psychol health: N= 59/109 15.6(3.5) 15.9(3.8) Ns 18.1(2.4) 17.1(2.9) P < 0.0001; 0.009
Independence: N= 57/109 12.9(3.7) 12.6(2.9) Ns 16.1(2.4) 15.7(2.4) P < 0.0001; 0.0001
Social relations: 
N= 58/105
9.6(2.8) 9.8(2.6) Ns 11.5(1.7) 10.8(2.5) P < 0.0001; 0.006
Environment: N= 57/102 27.5(5.4) 27.5(5.1) Ns 28.3(4.4) 28.3(5.3) P = 0.4; 0.3
Spiritual N = 59/108 3.2(1.0) 3.5(1.0) Ns 3.7(0.9) 3.7(1.0) P < 0.005; 0.2
General facet: N= 59/107 6.9(1.6) 6.7(1.7) Ns 8.1(1.2) 7.9(1.5) P < 0.0001; 0.0001
4- domain physical health 22.6(5.7) 22.1(4.8) Ns 27.3(3.8) 26.3(3.9) P < 0.0001; 0.0001
4- domain psychol health 18.8(4.3) 19.3(4.5) Ns 21.8(3.1) 20.8(3.8) P < 0.0001; 0.009
B. By MS type
WHOQOL-Bref domains RRMS (SD): 1 PMS (SD): 2 T P level Control (SD): 3
N = 171
P level differences b/w 
pts & control groups:
1 vs 3; 2 vs 3, 
respectively**
Physical health: N = 141/
25
10.0(2.1) 7.6(2.9) 5.1 0.001 10.8(1.9) P < 0.005; 0.0001
Psychol health: N = 143/25 16.4(3.1) 12.0(4.8) 5.9 0.001 17.4(2.8) P < 0.003; 0.0001
Independence: N = 142/24 13.2(2.7) 9.2(4.1) 6.3 0.001 15.9(2.3) P < 0.0001; 0.0001
Social relations: N= 140/
24
10.3(2.2) 6.5(3.2) 7.2 0.001 11.1(2.2) P < 0.002; 0.0001
Environment: N = 135/24 28.4(4.6) 22.4(5.7) 5.7 0.001 28.3(4.9) P = 0.9; 0.0001
General facet: N = 142/25 7.1(1.2) 5.0(2.3) 6.7 0.001 8.0(1.4) P < 0.0001; 0.0001
* For significant differences: t ranged from 2.6 to 8.6, df = 117, 215, respectively
** For significant differences: t ranged from 2.9 to 9.5, df = 309, 193, respectively.BMC Neurology 2007, 7:31 http://www.biomedcentral.com/1471-2377/7/31
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Suicidal ideation
Patients who had this complaint " most times" had a ten-
dency to have the lowest QOL domain scores. But this
reached significance for only the spiritual domain (F = 6.1
df = 2/147, P = 0.003).
Feeling of fatigue
The tendency for patients with this complaint " most
times" to have lower QOL reached significance for only
the spiritual domain (F = 5.3, df = 2/149, P = 0.006).
Difficulty in breathing as side effect of treatment
There was a tendency for those who had this complaint "
most times" to have lower QOL scores. This reached sig-
nificance for the spiritual domain (F = 7.2 df = 2/149 P =
0.001), and general facet (F = 4.2 df = 2/150, P = 0.02)
Factors associated with QOL domain scores in 
multivariate relationship (Table 5)
In view of the many univariate relationships, the data
were subjected to analysis of covariance (ANCOVA), to
examine the factors that impact on QOL in multivariate
relationship, and control for the effect of these relation-
ships in the differences in QOL between the RRMS and
PMS. Table 5 shows that, of all the above variables, the
most important factors associated with QOL domain
scores were depression and disability, with age playing a
relatively minor role. Of note, the diagnosis effect (i.e.,
whether patient had RRMS or PMS) was significant
mainly for general facet on health and QOL (P = 0.007).
Accordingly, when the impact of the variables were con-
trolled for in ANCOVA, to assess QOL domain differences
between RRMS and PMS, we found that, the highly signif-
icant differences noted in Table 4 became significant only
for the general facet (P = 0.005).
Patient's current feeling of well-being (Table 6)
In all the domains, patients who felt currently well had
significantly higher QOL scores (P < 0.01).
Association of immuno-modulatory treatment with QOL 
(Table 7)
Those on the three types of immuno-modulatory drugs
had similar QOL scores, and their scores tended to be
higher than those not on immuno-modulatory treatment.
Those on Rebif had significantly higher scores than those
not on immuno-modulatory drugs, for physical health,
independence and general facet (P < 0.05). A similar trend
was noted for depression and disability, where those on
immuno-modulatory treatment had lower scores (P <
0.05).
Concordance of patient's and caregiver's QOL ratings 
(Tables 8 &9)
Table 8 shows that there was a high degree of concordance
between the patient's and caregiver's QOL ratings, both at
the level of items (P mostly < 0.001) or at the macro level
of domain scores (P mostly < 0.0001). In addition, the
Table 6: Comparison of QOL domains: patients feeling currently 
well versus feeling currently ill*
QOL domains Feel 
currently
 ill
Mean(SD)
Not feel ill 
currently
Mean(SD)
TD fP
Physical health: 
N = 124/40
9.3(2.4) 10.8(2.3) 3.3 162 0.001
Psychological health: 
N = 125/41
15.3(3.9) 17.1(2.7) 2.7 164 0.007
Independence: N = 
124/40
12.2(3.2) 14.1(3.2) 3.3 162 0.001
Social relations: 
N = 120/42
9.4(2.8) 10.8(2.1) 3.1 160 0.003
Environment:
N = 118/40
26.9(5.3) 29.4(4.7) 2.7 156 0.008
Spiritual: N = 124/41 3.2(1.1) 3.9(0.8) 3.6 163 0.001
General facet health & 
QOL: N = 125/40
6.6(1.7) 7.5(1.3) 3.2 163 0.002
4 -d Physical health:
N = 123/39
21.5(4.9) 24.7(5.1) 3.4 160 0.001
4 -d Psychological 
health: N = 124/41
18.5(4.7) 20.9(3.1) 3.2 163 0.002
* Caregiver impression ratings: The caregivers rated the patients in the 
same direction, such that, in all domains, patients who felt well were 
judged to have significantly higher QOL scores. Except the spiritual 
domain (t = 1.9, P = 0.053), t ranged from 2.4 to 4.4,, df ranged from 
138 – 143, P ranged from 0.02 to 0.000 (mostly P < 0.0001).
Table 5: Factors associated with QOL: significant covariates of 
QOL domains in ANCOVA*
Significant factors or 
covariates
QOL domains 
significantly impacted by 
covariates
F P level
Depression: total BDI 
scores
Psychological health 13.4 0.0001
Physical health 6.3 0.01
Independence 10.0 0.002
Social relations 4.7 0.03
Spiritual 19.2 0.001
Disability score: EDSS Physical health 10.3 0.002
Social relations 4.4 0.04
Environment 4.1 0.05
Age of patient Independence 3.9 0.05
Social relations 5.2 0.02
Diagnosis effect Social relations 4.2 0.04
Spiritual 4.1 0.05
General facet health & 
QOL
7.6 0.007
* Note: After controlling for these covariates, the large differences in 
QOL domain scores between the RRMS and PMS earlier highlighted 
(Table 4), was significant only for the general facet on health & QOL (P 
< 0.005).BMC Neurology 2007, 7:31 http://www.biomedcentral.com/1471-2377/7/31
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intra-class correlation between the total responses of the
patients and those of the caregivers was very high (ICC =
0.96, 95% C.I. = 0.95 – 0.97). Accordingly, the significant
differences between the QOL domain scores of the
patients and those derived from caregiver impression rat-
ings were noted for only the environment domain and
general facet (P = 0.002), where the patients rated them-
selves as having higher scores than the caregivers rated
them (Table 9).
Predictors of overall QOL (Table 10)
In multiple regression analysis, with the general facet on
health and QOL as dependent variable, and all other fac-
tors as independent variables, the only significant predic-
tors of patients' overall QOL were, disability status (P <
0.0001), general facet derived from caregiver impression
of patients' QOL (P < 0.0001), and caregivers' fear of hav-
ing the illness (P = 0.03). These accounted for 46.9% of
the variance.
Discussion
Limitations and strengths of the study
The limitations of the study are that it was cross-sectional,
the patients were selected because they had family sup-
port, involving only subjects from one center, and so the
subjects may not be representative of the general popula-
tion of MS patients in Kuwait. However, this hospital is
the national center for neurology, where the vast majority
of MS patients are referred to, and the socio-demographic
and clinical characteristics of our patients were much sim-
ilar to those of the Kuwait epidemiologic sample [26]. The
epidemiologic sample consisted of 336 patients (41.7%
men, 58.3% women) recruited over a period of seven
years (1993–2000) at the same hospital. Our sample of
170 patients was similar to the epidemiologic sample in
terms of gender distribution(35.5% men, 64.5% women),
age at onset of disease (27.1 Vs 26.0), diagnostic types of
MS (RRMS: 85.3% Vs 78.4%), and type of treatment
(0.6% of each sample were on glatiramerate acetate, while
others were mostly on beta interferon). Hence our sample
size and the characteristics of the patients were represent-
ative of the Kuwaiti clinical population and sufficient to
test the hypotheses of the study. In our review of several
recent MS reports from the western world (i.e., western
Europe and north America) we found that their clinic
samples were usually averagely aged over 41 years, had a
mean age at onset of 29.5 to 34.3 (mostly over 30) years,
mean EDSS scores were mostly over 4.0 (range 2.8 to 4.5),
patients with mild severity (EDSS score 0–3.5) ranged
from 21.3% to 47.9%, those with RRMS ranged from
28.9% to 75.3%, and the proportion in employment
ranged from 25% to 40% [8,15,16,19,41-44]. In a review
of the epidemiology of MS in Europe, it was noted that the
prevalence of mildly severe MS was 45 – 55% [25]. When
these reported clinical characteristics of MS in the western
world were compared with our sample, we found that our
data were in line with the impression of clinicians in
Kuwait, that our patients are relatively younger, tend to
have an earlier age at onset of disease, tend to have a
milder severity of illness, and tend to be more able to sus-
tain their employment (Tables 1 &2) [26,27]. It is against
this background of apparent differences in clinical charac-
teristics that our results will be compared with western
reports.
The other strengths of the study are that we were able to
compare the MS groups with a gender-, age-, education-,
occupation-, and marital status- matched general popula-
Table 7: QOL domain scores: patients on immuno-modulatory drugs vs patients not on immuno-modulatory drugs
QOL domains Rebif: 1 N = 14
Mean(SD)
Avonex: 2 N = 75
Mean(SD)
Betaseron: 3 N = 54
Mean(SD)
Other drugs: 4 N = 9
Mean(SD)
F Df P Significantly 
different 
groups
Physical health 10.7(2.2) 9.5(2.4) 9.6(2.2) 7.7(2.8 3.1 3/144 0.03 1 > 4
Psychol health 16.3(2.8) 15.5(3.6) 15.6(3.8) 15.4(4.9) 0.9 -
Independence 13.1(2.7) 12.5(2.9) 12.7(3.5) 9.9(3.9) 2.2 3/146 0.05 1 & 3 > 4
Social 
relations
9.1(2.7) 9.8(2.4) 9.6(2.9) 8.9(2.8) 0.6 -
Environment 26.2(4.2) 27.6(5.3) 27.1(5.0) 25.0(5.4) 0.5 -
Spiritual 3.1(1.2) 3.4(0.9) 3.3(0.9) 3.3(1.4) 0.8
General facet 7.3(1.5) 6.8(1.6) 6.7(1.9) 5.8(1.9) 2.1 3/147 0.05 1 > 4
Depression(B
DI)*
16.3(8.3) 15.4(10.3) 12.3(9.3) 21.6(25.8) 2.0 3/127 0.05 4 > 3*
Disability(EDS
S)
3.4(1.3) 2.7(1.7) 2.6(2.0) 4.4(2.5) 2.9 3/147 0.04 4 > 2 & 3
* Effect size (ES) calculations(95% C.I.) : 4 Vs 1: ES = 0.31(- 0.54 – 1.14); 4 Vs 2: ES = 0.49 (- 0.21 – 1.18); 4 Vs 3: ES = 0.73(0.00 – 1.18)
Duration of drug treatment: Mean = 2.9(2.6), range = 0.5 – 14 yrs, median = 2.5 yrs, mode = six months
Only one subject was on glatiramer acetate (copaxone), not included in this analysis.BMC Neurology 2007, 7:31 http://www.biomedcentral.com/1471-2377/7/31
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tion group, and assessed the relationship of caregiver
impression of the patient's QOL and caregiver attitudes to
the patient, with the QOL of the patient. This is a rare
methodology in MS QOL literature. Furthermore, we have
shown that despite skepticism about its use in MS[4], the
WHOQOL-Bref performed very well in this study, as it sig-
nificantly discriminated between known groups (e.g.,
RRMS versus PMS; MS versus control group; patients feel-
ing currently well versus those feeling sick). Also, it had
impressive external criterion validity, as the domain
scores were highly significantly correlated with depression
and disability.
Comparison of QOL item ratings and domain scores
In analyzing for the first hypothesis (Table 3), we found
that the only items of the WHOQOL-Bref that the patients
were moderately or highly satisfied with (i.e., > 66% of
subjects responded satisfied/very satisfied) were money
for needs and transport. Otherwise, they were predomi-
nantly dissatisfied with items related to their health con-
dition, such as pain, reliance on treatment, ability to
concentrate and ability to get around.
The ratings of the family caregivers about the patients'
QOL were largely similar to those of the patients. This
response pattern is an indication of the reliability of the
ratings of the patients. For, while they were highly satis-
fied with items related to their materially affluent national
circumstances (availability of money and transport), they
were dissatisfied with items related to their general health
situation. It shows that in rating subjective QOL, the
patients and caregivers made realistic appraisals of their
life circumstances. However, the patients were barely sat-
isfied with items of social support that we logically
expected them to be highly satisfied with in a conservative
culture, such as personal relations and support from
friends. This response pattern is comparable to what was
obtained from psychiatric and diabetic patients in Sudan,
a similarly conservative country, but with much lower
national material affluence [31-34]. While the Sudanese
psychiatric patients and those with type 1 diabetes were
not satisfied with any items up to the moderate level,
patients with type 2 diabetes were moderately satisfied
with items related to life being meaningful, self -satisfac-
tion, and condition of living place. In cross-national Euro-
pean studies, it was found that the level of satisfaction in
certain domains appeared to be associated with the local
style of living and culture, while other areas appeared to
be more independent of local variations [45].
In line with this high level of dissatisfaction, our MS
patients had QOL domain scores that were significantly
lower than those of the control group in all the domains,
except the environment and spiritual domains (Table 4).
There were no significant gender differences, and in the
uncorrected scores, those with RRMS had much signifi-
cantly higher scores than those with the progressive types
of MS. These findings are in line with the vast majority of
reports from the western world and elsewhere [6,18-22].
However, a USA study found that, while patients had
lower scores than the general population in most
domains, 77% of the patients were mostly satisfied or
delighted with their QOL [30], and the patients had simi-
lar scores with the general population in some domains.
In comparing the QOL domain scores of our MS patients
with those of psychiatric (N = 300) and diabetic (N = 241)
patients similarly assessed in Sudan [31,33], we found
that our Kuwaiti patients had similar scores with the Suda-
nese diabetic patients for the following domains: general
facet (mean 6.8 in each case), physical health (mean 9.7
in each case), and independence (mean 12.6 in each
Table 8: Correlation of patient's rating and caregiver impression 
for QOL items (Kendal's tau)*
WHOQOL-Bref items Kt N P
Overall rating QOL 0.33 145 0.001
Health satisfaction 0.27 146 0.001
Pain feelings 0.15 144 0.03
Medical treatment need -0.15 141 0.03
Enjoyment of life -0.08 144 0.26
Life meaningful 0.19 144 0.007
Ability to concentrate 0.28 144 0.001
Safety in daily life 0.35 144 0.001
Environmental health 0.24 144 0.001
Energy for life 0.36 143 0.001
Bodily appearance 0.33 144 0.001
Enough money for needs 0.31 141 0.001
Available information for health 0.23 142 0.001
Leisure opportunity 0.26 142 0.001
Ability to get around 0.45 142 0.001
Sleep satisfaction 0.24 145 0.001
Activities of daily living 0.23 145 0.001
Work capacity 0.35 146 0.001
Self -satisfaction 0.27 145 0.001
Personal relationships 0.37 144 0.001
Satisfaction with sex life 0.37 141 0.001
Satisfaction with friends' support 0.27 146 0.001
Condition of place of living 0.25 142 0.001
Access to health service 0.14 146 0.06
Satisfaction with transport 0.28 146 0.001
Negative feelings 0.20 146 0.005
QOL domains R N P
Physical health 0.37 141 0.001
Psychological health 0.33 141 0.001
Independence 0.34 137 0.001
Social relations 0.35 137 0.001
Environment 0.40 132 0.001
Spiritual 0.19 144 0.007
General facet health & QOL 0.29 145 0.001
* Intra-class correlation coefficient (ICC) for Pts WHOQOL-Bref & 
Caregiver impression: ICC = 0.96 (95% C.I. = 0.95–0.97)BMC Neurology 2007, 7:31 http://www.biomedcentral.com/1471-2377/7/31
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case). Also, the Kuwaiti MS patients had similar scores
with the Sudanese psychiatric patients for the following
domains: social relations, spiritual, psychological health
and physical health (P > 0.05). However, the Sudanese
diabetic patients had significantly higher scores than the
Kuwaiti MS patients for the following domains: social
relations (P < 0.04), spiritual (P < 0.009), and psycholog-
ical health (P < 0.002). The Kuwaiti patients had signifi-
cantly higher scores than the Sudanese diabetic (P < 0.03)
and psychiatric (P < 0.001) patients for the environment
domain. While the higher Kuwaiti score for the environ-
ment domain (which includes money and transport) is a
reflection of their better material circumstance, the higher
Sudanese score for social relations domain was a surpris-
ing finding, in view of the presumed higher social support
in Kuwait. We shall seek to explain this finding later.
Although the relatively lower QOL domain scores of our
patients in comparison with the general population is in
line with the literature, and shows the adverse impact of
MS on psychosocial functioning even for those with
milder disease course, we were still surprised that our
patients showed such a high level of dissatisfaction with
their life circumstances, as expressed in the items of
WHOQOL-Bref. However, in a recent report on posttrau-
matic stress disorder (PTSD) among Kuwaiti veterans of
the first Gulf War and their wives, it was found that,
despite a generous national welfare and family social sup-
ports, the prevalence of PTSD remained high among the
sample, six years after the war [46]. In other words, health
impairment can adversely affect a patient's capacity to
benefit from available social support, especially as physi-
cal health is a strong correlate of subjective well-being
[47], and it has been shown that the association between
social resources and life satisfaction is mediated through
health impairment [48,49]. In a study of social support as
a mediator in the relationship between functional status
and QOL, it was found that impairment was associated
with fewer friendship contacts, fewer family contacts, less
perceived belonging and less perceived tangible aid [50].
Factors associated with QOL
In analyzing for the second hypothesis, we found that
depression and disability were the most important factors
in multivariate relationship. This finding has been
robustly replicated in the literature [3,5-7,19,23,44].
Accordingly, we found that when these two factors were
controlled for, the previously noted differences between
the RRMS and PMS became significant for only the gen-
eral facet on health and QOL. The implication of this find-
ing is that the clinician has to routinely assess, treat and
counsel the patient for depression and limitation of
movements. Some authors [51] have considered that the
high level of correlation between BDI and QOL domain
scores indicates measurement overlap, and have suggested
that the assessment of subjective QOL should always be
checked for the influence of depressive symptomatology
on QOL scores. Our ANCOVA operation adequately
addressed this issue.
In the case of side effects of treatment, the noteworthy
finding was that those who were worried by the effects of
treatment were significantly more likely to feel that life
was not meaningful (i.e., lower score on spiritual
domain). On the other hand, those on immuno-modula-
tory drugs and those who felt currently well consistently
tended to have higher QOL domain scores, lower depres-
sion scores, and lower disability scores, compared with
those who were not on immuno-modulatory treatment
(Tables 6 &7). In other words, while the patients should
Table 10: Predictors of patient's QOL: general facet health & QOL as dependent variable*
Dependent variable Predictors Variance (%) Total (%) Standard Beta T P
Patient's general facet on health 
& QOL
Disability score 34.0 46.9 -0.46 -5.3 0.001
Caregiver impression general facet health & QOL 10.1 0.32 3.6 0.001
Caregiver anxious about having MS 2.8 -0.17 -2.2 0.03
* Variables not in the step-wise regression equation: age of patient, duration of illness, age at onset of illness, caregiver feeling sad about patient's 
illness, caregiver feeling disgusted with patient's condition, caregiver feeling tired/exhausted about caring for patient, BDI total score, general facet 
for caregiver.
Table 9: Comparison of patient's ratings and caregiver 
impression scores for WHOQOL-Bref domains
QOL domains Patients: 
Mean(SD)
Caregiver 
impression: 
Mean(SD)
TD f P
Physical 
health
9.9(2.1) 9.8(1.8) ns
Psychological 
health
16.4(3.1) 15.9(2.3) ns
Independence 13.1(2.7) 12.8(2.2) ns
Social 
relations
10.3(2.3) 10.0(2.3) ns
Environment 28.4(4.6) 27.0(4.6) 3.1 114 0.002
Spiritual 3.5(0.9) 3.5(0.9) ns
General facet 
health & QOL
7.1(1.2) 6.7(1.5) 3.2 124 0.002BMC Neurology 2007, 7:31 http://www.biomedcentral.com/1471-2377/7/31
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be encouraged to be compliant with treatment, they
should be routinely monitored for side effects of treat-
ment.
Concordance of patient -caregiver ratings of patient's 
QOL
In analyzing for the third hypothesis, we found that there
was a high degree of concordance between the ratings of
the patients and family caregivers' impression of the
patients' QOL (Tables 8 &9). Coupled with the high relia-
bility indices of the questionnaires, this is an indication
that this sample of patients was realistic in their responses
and did not show evidence of unawareness of functional
deficit [13]. The findings are in line with the reports from
Sudan on similarly assessed patients [31-34].
Predictors of QOL
In analyzing for the fourth hypothesis, we found that the
predictors of general facet on health and overall QOL were
disability status, family caregiver impression of the
patients' QOL, and caregiver being anxious about the pos-
sibility of having the illness (Table 10). The predictive
power of caregiver impression has now been replicated for
patients with chronic medical illnesses in Sudan[31-
34,52] and Kuwait, and should therefore be regarded as
noteworthy. The implication of this finding is that the cli-
nician should assess and address family caregivers' anxiety
over fear of developing the illness, and improve their
awareness about the nature and management of multiple
sclerosis. We suggest that recent brain -behavior findings
about "mirror neurons"[53] and the phenomenon of
"social intelligence"[54] indicate that the patient- car-
egiver dyad interaction and its association with QOL has
roots in the neurology of human behaviour [52-54].
Conclusion
Our data indicate that MS patients in stable clinical condi-
tion and with social supports can hope to have better
QOL, if clinicians pay attention to depression, disability,
the impact of side effects of treatment and family caregiver
anxieties about the illness. Patients who are older, less
educated and unemployed are particularly vulnerable and
need specific attention. The findings constitute an evi-
dence base for the establishment of a regular program of
psychosocial intervention in our clinical setting, to
address these issues and provide caregiver education and
supports, in order to enhance the quality of care.
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